Kazakhstan:
GRATA International Held The Meeting Of Working Group On Legal Issues At The CCI France - Kazakhstan
09 June 2021
GRATA International
To print this article, all you need is to be registered or login on Mondaq.com.
On September 30, 2020, the online meeting on theme:
"Data exclusivity: legal significance
for the pharmaceutical industry in Kazakhstan" was
held.
The speaker was Leila Makhmetova – Counsel and the
Director of Environmental Law Department of GRATA International,
where she told about:
- The introduction of Data exclusivity
- The purpose and objectives of data exclusivity
- The data exclusivity in Kazakhstan
- Foreign experience ( Russia, Armenia, USA, European union)
You can see the speaker's presentation
here→
The webinar record is available here→
Originally published 1 October 2020
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from Kazakhstan
Elderly Care FAQ
Wrigleys Solicitors
These FAQs cover topics related to caring for elderly relatives. It discusses how to place an elderly person in a care home, the absence of legal obligation for family members to provide long-term care...
Life Science Update: April 2024
Kromann Reumert
Welcome to this edition of Kromann Reumert's Life Science Update. In the following, we provide an overview of recent legal updates that will have a bearing on the life science industry across Europe...
Life Sciences 2024
Bär & Karrer
Swiss healthcare regulation is spread over various statutes, ordinances and guidelines, including self-regulatory instruments such as best practice codes and references to international provisions.